Company

Pliant Therapeutics, Inc.

San Francisco biotech developing oral small molecule integrin inhibitors for fibrotic diseases, founded in 2015.

About

Pliant Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, US. The biotechnology company develops therapies for fibrotic diseases, with two clinical-stage programs built on oral, selective small molecule integrin inhibitors. It raised USD 200.000 mn in a Private Placement in July 2022, and its CEO is Bernard Coulie. For fiscal year 2022 the company reported revenue of USD 9.685 mn and an EBITDA of USD -223.730 mn.

3Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in